Abstract
Background
The Oral Care Study Section of the Multinational Association of Supportive Care in Cancer (MASCC) and the International Society for Oral Oncology (ISOO) conducted a survey on clinical practices of oral/dental management of cancer patients among supportive health care providers. The main purpose was to evaluate the knowledge and current practice for preventing and managing oral side effects associated with intensive chemotherapy (ICT), hematopoietic cell transplant (HCT), and radiation therapy to the head and neck (H&N RT).
Materials and methods
A questionnaire designed and pretested was sent to 212 MASCC/ISOO members around the world with different dental and medical backgrounds.
Main results
Seventy-four individuals (35%) responded. The majority of respondents were aware of possible oral complications and provided patients with clinical strategies and recommendations although there was considerable variability among the respondents. Approximately 75% stated that patients were referred for oral/dental care prior to H&N RT and ICT including HCT. However, integrated dental and medical services were reported available in only about 25% of the institutions, and most patients were referred to community-based dental professionals.
Main conclusions
The survey represents a first review of current, international oral care practices. It suggests a need to develop evidence-based clinical guidelines to support effective oral/dental interventions and management strategies for this population. Furthermore, strategies for implementation of oral care protocols and better integration of dental and medical services should be developed. Caution in interpreting these findings is urged due to the limited response rate.
Similar content being viewed by others
References
Barasch A, Peterson DE (2003) Risk factors for ulcerative oral mucositis in cancer patients: unanswered questions. Oral Oncol 39:91–100
Barker G (1999) Current practices in the oral management of the patient undergoing chemotherapy or bone marrow transplantation. Support Care Cancer 7:17–20
Beck S (1979) Impact of a systemic oral care protocol on stomatitis after chemotherapy. Cancer Nursing 2:185–199
Beck SL (2002) Strategies to translate research into practice. Semin Oncol Nurs 18:11–19
Bellm LA, Epstein JB, Rose-Ped A, Martin P, Fuchs HJ (2000) Patient reports of complications of bone marrow transplantation. Support Care Cancer 8:33–39
Bonaure-Malet M, Bunetel L, Tricot-Doleux S, Guerin J, Bergeron C, Legall E (1998) Oral complications during treatment of malignant diseases in childhood: effects of tooth brushing Eur J Cancer 34:1588–1591
Bondi E, Baroni C, Prete A, Gatti M, Carassi A, Lodi G, Porter SR (1997) Local antimicrobial therapy of oral mucositis in paediatric patients undergoing bone marrow transplantation. Oral Oncol 33:322–326
Borowski B, Benhamou E, Pico JL, Laplanche A, Margainaud JP, Hayat M (1994) Prevention of oral mucositis in patients treated with high-dose chemotherapy and bone marrow transplantation: a randomized controlled trial comparing two protocols of dental care. Eur J Cancer B Oral Oncol 30B: 93–97
Carl W (1995) Oral complications of local and systemic cancer treatment. Curr Opin Oncol 7:320–324
Cheng KK, Molassiotis A, Chang AM, Wai WC, Cheung SS (2001) Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur J Cancer 37:2056–2063
Cooper JS, Fu K, Marks J, Silverman S (1995) Late effects of radiation therapy in the head and neck region. Int J Radiat Oncol Biol Phys 31:1141–1164
Dodd MJ, Dibble S, Miaskowski C, Paul S, Cho M, MacPhail L, Greenspan D, Shiba G (2001) A comparison of the affective state and quality of life of chemotherapy patients who do and do not develop chemotherapy-induced oral mucositis. J Pain Symptom Manage 21:498–505
Dodd MJ, Miaskowski C, Greenspan D, MacPhail L, Shih AS, Shiba G, Facione N, Paul SM (2003) Radiation-induced mucositis: a randomized clinical trial of micronized sucralfate versus salt & soda mouthwashes. Cancer Invest 21:21–33
Donnelly JP (1995) Bacterial complications of transplantation: diagnosis and treatment. J Antimicrob Chemother 36 [Suppl B]:59–72
Donnelly JP, Bellm, LA, Epstein JB, Sonis ST, Symonds RP (2003) Antimicrobial therapy to prevent oral mucositis. Lancet Infect Dis 3:405–412
Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB (2003) The burdens of cancer therapy. Clinical and economic outcomes of chemotherapy-induced mucositis. Cancer 98:1531–1539
Epstein JB, Schubert MM (1999) Oral mucositis in myelosuppressive cancer therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 88:273–276
Epstein JB, Stevenson-Moore P (2001) Periodontal disease and periodontal management in patients with cancer. Oral Oncol 37:613–619
Epstein JB, Rea G, Wong FL, Spinelli J, Stevenson-Moore (1987) Osteonecrosis: study of the relationship of dental extractions in patients receiving radiotherapy. Head Neck Surg 10:48–54
Epstein JB, Ransier A, Lunn R, Chin E, Jacobson JJ, Le N. Reece D (1996) Prophylaxis of candidiasis in patients with leukemia and bone marrow transplants. Oral Surg Oral Med Oral Pathol Oral Radiol Endodod 81:291–296
Epstein JB, Robertson M, Emerton S, Phillips N, Stevenson-Moore P (2001) Quality of life and oral function in patients treated with radiation therapy for head and neck cancer. Head Neck 23:389–398
Epstein JB, Tsang AH, Warkentin D, Ship JA (2002) The role of salivary function in modulating chemotherapy-induced oropharyngeal mucositis: a review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 94:39–44
Epstein JB, Parker IR, Epstein MS, Stevenson-Moore P (2004) Cancer-related oral health care services and resources: a survey of oral/dental care in provincial cancer centers. J Can Dent Assoc 70(5):302–304
Gabriel DA, Shea T, Olajida O, Serody JS, Comeau T (2003) The effect of oral mucositis on morbidity and mortality in bone marrow transplant. Semin Oncol 30 [Suppl 18]:76–83
Heimdahl A (1999) Prevention and management of oral infection in cancer patients. Support Care Cancer 7:224–228
Honor A, Law A (2002) Mouth care in cancer nursing: using an audit to change practice. Br J Nurs 11:1087–1096
Levy-Polack MP, Sebelli P, Polack NL (1998) Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec Care in Dentist 18:189–193
McGuire DB (2002) Mucosal tissue injury in cancer therapy. More than mucositis and mouthwash. Cancer Pract 10:179–191
McGuire DB (2003) Barriers and strategies in implementation of oral care standards for cancer patients. Support Care Cancer 11:435–441
Miller CS, Epstein JB, Hall EH, Sirois D (2001) Changing oral needs in the United States: the continuing need for oral medicine. Oral Surg Oral Med Oral Pathol Radiol Endod 91:34–44
Milligan S, McGill M, Sweeney MP, Malarkey C (2001) Oral care for people with advanced cancer: an evidence-based protocol. Int J Palliat Nursing 7:418–426
NCI Monograph (1990) National Institutes of Health Consensus Development Conference on Oral Complications of Cancer Therapies: Diagnosis, Prevention, and Treatment. Bethesda, Maryland April 17–19, 1989
Öhrn KE, Wahlin YB, Sjoden PO (2001) Oral status during radiotherapy and chemotherapy: a descriptive study of patients experiences and the occurrence of oral complications. Support Care Cancer 9:247–257
Peterson DE, Overholser C, Williams L, Newman K, Schimpff S, Hahn D, Wiernik P (1980) Reduced periodontal infection in patients with acute non-lymphocytic leukaemia following rigorous oral hygiene. Proc Am Soc Clin Oncol 21:438
Raber-Durlacher JE, Epstein JB, Raber J, van Dissel JT, van Winkelhoff AJ, Guiot HF, van der Velden U (2001) Periodontal infection in cancer patients treated with high-dose chemotherapy. Support Care Cancer 10:466–473
Ransier A, Epstein JB, Lunn R, Spinelli J (1995) A combined analysis of a toothbrush, foam brush, and Chlorhexidine-soaked foam brush in maintaing oral hygiene. Cancer Nurs 8:393–396
Reuscher TJ, Sodeifi A, Scrivani SJ, Kaban LB, Sonis ST (1998) The impact of mucositis on alpha-hemolytic streptococcal infections in patients undergoing autologous bone marrow transplantation for hematologic malignancies. Cancer 82:2275–2781
Rose-Ped AM, Bellm LA, Epstein JB, Trotti A, Gwede C, Fuch HJ (2002) Complications of radiation therapy for head and neck cancers. The patient’s perspective. Cancer Nurs 25:468–469
Rubenstein EB, Peterson DE, Schubert MM, Keefe D, McGuire D, Epstein JB, Elting LS, Fox PC, Loprinzi CL, Sonis ST (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 1(100) [Suppl 9]:2026–2046
Sadler GR, Stoudt A, Fullerton JT, Oberle-Edwards LK, Nguyen Q, Epstein JB (2003) Managing the oral sequelae of cancer therapy. Medsurg Nurs 12:28–36
Scully C, Sonis ST, Epstein JB (2004) Oral mucositis: A challenging complication of radiotherapy, chemotherapy, and radiochemotherapy. Part 2: Diagnosis and management of mucositis. Head Neck 26:77–84
Seto BG, Kim M, Wolinsky L, Mito RS, Champlin R (1985) Oral mucositis in patients undergoing bone marrow transplantation. Oral Surg Oral Med Oral Pathol 60:493–497
Slots J (2003) Update on general health risk of periodontal disease. Int Dent J 53 [Suppl 3]:200–207
Sonis ST (1998) Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatoxicity. Oral Oncol 34:39–43
Sonis ST, Oster G, Bellm L, Bradford WZ, Edelsberg J, Hayden V, Eilers J, Epstein JB, LeVeque FG, Peterson DE, Schubert MM, Spijkervet FK, Horowitz M (2001) Oral mucositis and the clinical and economic outcomes of hematopoietic stem-cell transplantation. J Clin Oncol 19:2201–2205
Sonis ST, Scherer J, Phelan S, Lucey CA, Barron JE, O’Donnell KE, Brennan RJ, Pan H, Busse P, Haley JD (2002) The gene expression sequence of radiated mucosa in an animal mucositis model. Cell Prolif 35 [Suppl 1]:93–102
Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert MM, Hauer-Jensen M, Bekele BN, Raber-Durlacher JE, Donnelly JP, Rubenstein E (2004) Perspectives on Cancer Therapy-Induced Mucosal Injury: Pathogenesis, Measurement, Epidemiology, and Consequences for Patients Cancer 1(100) [Suppl 9]:1995–2025
Stiff P (2001) Mucositis associated with stem cell transplantation: current status and innovative approaches to management. Bone Marrow Transplant 27 [Suppl 2]:S3–S11
Stokman MA, Spijkervet FK, Burlage FR, Dijkstra PU, Manson WL, de Vries EG, Roodenburg JL (2003) Oral Mucositis and selective elimination of oral flora in head and neck cancer patients receiving radiotherapy: a double-blind randomised clinical trial. Br J Cancer 88:1012–1016
Summary of report of IOM Committee on the Future of Dental Education, “Dental Education at the Crossroads: Challenges and Change”. (1998) J Public Health Dent 58 [Suppl]:107–113
Symonds RP, McIlroy P, Khorrrami J, PaulJ, Pyper E, Alcock SR, McCallum I, Speekenbrink AB, McMurray A, Lindemann E, Thomas M (1996) The reduction of radiation mucositis by selective decontamination antibiotic pastilles: a placebo-controlled double-blind trial. Br J Cancer 74:312–317
Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilverberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66:253–262
Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP (2003) Oral sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14:199–212
Wang CC, Nakfoor BM, Spiro IJ, Martins P (1997) Role of accelerated fractionated irradiation for supraglottic carcinoma: assessments of results. Cancer J Sci Am 3:88–91
White BA (1995) The costs and consequences of medically neglected oral care. Spec Care Dentist 15:180–186
Woo SB, Lee SJ, Schubert MM (1997) Graft-vs-Host disease. Crit Rev Oral Med 8:201–216
Acknowledgements
We would like to thank Ms. Terra Patterson, University of Missouri-Kansas City student assistant, for her conscientious assistance with data management.
Author information
Authors and Affiliations
Corresponding author
Additional information
For the Oral Care Study Section of the Multinational Association of Supportive Care in Cancer and the International Society for Oral Oncology. Chairs: Dr. Fred K. L. Spijkervet and Dr. Philip C. Fox.
Appendix
Appendix
Summary of oral care survey
-
1.
When are oncology patients at your institution or affiliated cancer programs referred for medically necessary oral–dental treatment?
-
2.
Are oncology patients referred for dental prophylaxis (cleaning)?
-
3.
Are oncology patients at your institution or affiliated cancer programs asked if they have a history of herpes simplex viral infection?
-
4.
Is a standardized oral assessment tool used for oncology patients?
-
5.
If a patient needs teeth extracted prior or during myelosuppressive chemotherapy, how many days of healing do you prefer prior to neutropenia?
-
6.
If a patient needs teeth extracted prior to radiation therapy to the head and neck, how many days of healing do you prefer prior to the start of radiation therapy?
-
7.
If a patient has a central venous catheter is antibiotic prophylaxis recommended prior to invasive dental procedures?
-
8.
Are oncology patients specifically instructed to brush his/her teeth?
-
9.
Is a different type of toothbrush or tooth-cleansing aid recommended during periods of neutropenia?
-
10.
Is the use of dental floss or an interdental cleaning aid recommended during chemotherapy?
-
11.
Is a mouthwash or mouth rinse recommended during chemotherapy?
-
12.
Is a mouthwash or mouth rinse recommended during radiation therapy to the head and neck?
-
13.
What protocol is recommended for patients with dentures?
-
14.
Are preventive-palliative measurements recommended for patients with dry mouth?
-
15.
Are palliative measures recommended for dry lips?
-
16.
Is a fluoride rinse or gel recommended for chemotherapy patients with dry mouth?
-
17.
Is a fluoride rinse or gel recommended for patients undergoing radiation therapy to the salivary glands?
-
18.
Are custom gel carriers recommended for fluoride application for patients undergoing radiation therapy to the salivary glands?
-
19.
Are other measures recommended to prevent radiation caries/demineralization?
-
20.
Are palliative measures/medications recommended for oral pain related to mucositis?
-
21.
Is a standardized mucositis scoring system/scale used to measure mucositis?
-
22.
Is a standardized pain scale used to measure pain related mucositis?
-
23.
Are sugary/high-carbohydrate snacks restricted between meals during cancer therapy?
-
24.
Are soda pops and highly sugared beverages restricted during cancer treatment?
Rights and permissions
About this article
Cite this article
Barker, G.J., Epstein, J.B., Williams, K.B. et al. Current practice and knowledge of oral care for cancer patients: a survey of supportive health care providers. Support Care Cancer 13, 32–41 (2005). https://doi.org/10.1007/s00520-004-0691-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-004-0691-5